Divi’s Laboratories Q4 results FY26: 1500% dividend announced; profit up 13.4% YoY to Rs 751 cr, revenue rises 9.5% YoY – Record date, quarterly earnings details – Markets

“Recommended a final dividend of ₹30/- (i.e. 1,500%) per equity share of face value ₹2/- each for the financial year 2025-26, subject to approval of the members at the ensuing 36th Annual General Meeting (AGM),” the pharmaceutical company said in an exchange filing.

The dividend shall be paid within specified timelines from the conclusion of the AGM. The 36th AGM of the members of the company will be held on August 10, 2026, it added.

The record date for the purpose of the payment of dividend is July 24, 2026.

Divi’s Laboratories Q4 results FY26

Divi’s Laboratories reported a Profit after tax (PAT) for the quarter at Rs 751 crore in the reporting quarter, representing a growth of 13.4 per cent year-on-year as against a PAT of Rs 662 crore posted for the corresponding quarter of the previous financial year.

The revenue from operations increased 9.5 per cent YoY to Rs 2,831 crore in Q4 FY26 against Rs 2,585 crore reported in the year-ago period.

The company said it earned a consolidated total income of Rs 2,986 crore for the quarter ended March 31, 2026 as against a consolidated total income of Rs 2671 crore for the corresponding quarter of the previous year.

EBITDA came in at Rs 934 ore in Q4 FY26 against Rs 886 crore in Q4 FY25, representing a growth of 5.4% YoY. EBITDA Margin was at 33 per cent in the reporting quarter against 34.3 per cent in the year-ago period.

Profit before tax (PBT) for the quarter amounted to Rs 963 crore as against a PBT of Rs 864 crore for the corresponding quarter of the previous year, it said.

For the current quarter, Divi’s Laboratories said it has forex gain of Rs 90 crore as against a forex gain of Rs 10 crore for the corresponding quarter of the previous year.

For the financial year 2025-26, the company earned a consolidated total income of Rs 11,067 crore as against Rs 9,712 crore for the previous financial year.

Profit before tax (PBT) for the current financial year amounted to Rs 3,388 crores (after the impact of labour codes of Rs 74 crores) as against Rs 2,916 crore for the previous financial year.

Profit After Tax (PAT) for the current financial year was Rs 2,568 crore as against Rs 2,191 crore for previous financial year.

For the current financial year, the forex gain stood at Rs 211 crore against a gain of Rs 48 crore for the previous financial year.

Divi’s Laboratories Share Price

(Disclaimer: The above article is meant for informational purposes only, and should not be considered as any investment advice. ET NOW DIGITAL suggests its readers/audience to consult their financial advisors before making any money related decisions.)